These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32157856)

  • 1. The Effectiveness of Sirolimus Treatment in Two Rare Disorders with Nonketotic Hypoinsulinemic Hypoglycemia: The Role of mTOR Pathway.
    Şıklar Z; Çetin T; Çakar N; Berberoğlu M
    J Clin Res Pediatr Endocrinol; 2020 Nov; 12(4):439-443. PubMed ID: 32157856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus therapy in infants with severe hyperinsulinemic hypoglycemia.
    Senniappan S; Alexandrescu S; Tatevian N; Shah P; Arya V; Flanagan S; Ellard S; Rampling D; Ashworth M; Brown RE; Hussain K
    N Engl J Med; 2014 Mar; 370(12):1131-7. PubMed ID: 24645945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extreme caution on the use of sirolimus for the congenital hyperinsulinism in infancy patient.
    Banerjee I; De Leon D; Dunne MJ
    Orphanet J Rare Dis; 2017 Apr; 12(1):70. PubMed ID: 28410602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of sirolimus therapy in familial hypoinsulinemic hypoglycemia caused by AKT2 mutation inherited from the mosaic father.
    Dushar M; Nowaczyk J; Pyrżak B; Akopyan H; Śmigiel R; Walczak A; Rydzanicz M; Płoski R; Szczałuba K
    Eur J Med Genet; 2021 Dec; 64(12):104368. PubMed ID: 34673243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphoproteomics and biomedical analytics coincide with clinical outcomes in supporting a constant but variable role for the mTOR pathway in the biology of congenital hyperinsulinism of infancy.
    Brown RE; Senniappan S; Hussain K; McGuire MF
    Orphanet J Rare Dis; 2017 Dec; 12(1):181. PubMed ID: 29246172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus therapy for congenital hyperinsulinism in an infant with a novel homozygous KCNJ11 mutation.
    Korula S; Chapla A; Priyambada L; Mathai S; Simon A
    J Pediatr Endocrinol Metab; 2018 Jan; 31(1):87-89. PubMed ID: 29176012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirolimus in the treatment of three infants with diffuse congenital hyperinsulinism.
    Al-Balwi R; Al-Atawi M; Al-Otaibi A; Babiker O; Al-Mutair A
    J Pediatr Endocrinol Metab; 2017 Aug; 30(9):1013-1017. PubMed ID: 28787272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTOR Inhibitors for the Treatment of Severe Congenital Hyperinsulinism: Perspectives on Limited Therapeutic Success.
    Szymanowski M; Estebanez MS; Padidela R; Han B; Mosinska K; Stevens A; Damaj L; Pihan-Le Bars F; Lascouts E; Reynaud R; Ferreira C; Bansept C; de Lonlay P; Saint-Martin C; Dunne MJ; Banerjee I; Arnoux JB
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4719-4729. PubMed ID: 27691052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of sirolimus in a neonate with persistent hypoglycaemia following near-total pancreatectomy for hyperinsulinaemic hypoglycaemia.
    Abraham MB; Shetty VB; Price G; Smith N; Bock Md; Siafarikas A; Resnick S; Whan E; Ellard S; Flanagan SE; Davis EA; Jones TW; Hussain K; Choong CS
    J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1391-8. PubMed ID: 26226122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus in severe hyperinsulinemic hypoglycemia.
    Mao S; Zhang A; Huang S
    N Engl J Med; 2014 Jun; 370(25):2448. PubMed ID: 24941188
    [No Abstract]   [Full Text] [Related]  

  • 11. Sirolimus in severe hyperinsulinemic hypoglycemia.
    Senniappan S; Brown RE; Hussain K
    N Engl J Med; 2014 Jun; 370(25):2448-9. PubMed ID: 24941187
    [No Abstract]   [Full Text] [Related]  

  • 12. A Novel Homozygous Mutation in the KCNJ11 Gene of a Neonate with Congenital Hyperinsulinism and Successful Management with Sirolimus.
    Ünal S; Gönülal D; Uçaktürk A; Siyah Bilgin B; Flanagan SE; Gürbüz F; Tayfun M; Elmaoğulları S; Araslı A; Demirel F; Ellard S; Hussain K
    J Clin Res Pediatr Endocrinol; 2016 Dec; 8(4):478-481. PubMed ID: 27181099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating AKT2 mutation: hypoinsulinemic hypoketotic hypoglycemia.
    Arya VB; Flanagan SE; Schober E; Rami-Merhar B; Ellard S; Hussain K
    J Clin Endocrinol Metab; 2014 Feb; 99(2):391-4. PubMed ID: 24285683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent hyperinsulinemic hypoglycemia of infancy: constitutive activation of the mTOR pathway with associated exocrine-islet transdifferentiation and therapeutic implications.
    Alexandrescu S; Tatevian N; Olutoye O; Brown RE
    Int J Clin Exp Pathol; 2010 Aug; 3(7):691-705. PubMed ID: 20830240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facial Dysmorphic Features in a Patient With Nonketotic Hypoglycemia and a Pathogenic Variant in the
    Ochoa Molina MF; Poggi H; De Toro V; Mendoza C; Hussain K
    AACE Clin Case Rep; 2022; 8(3):109-112. PubMed ID: 35602880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Hyperinsulinemic Hypoglycemia in a Neonate: Response to Sirolimus Therapy.
    Méder Ü; Bokodi G; Balogh L; Körner A; Szabó M; Pruhova S; Szabó AJ
    Pediatrics; 2015 Nov; 136(5):e1369-72. PubMed ID: 26504129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperinsulinemic Hypoglycemia.
    Güemes M; Hussain K
    Pediatr Clin North Am; 2015 Aug; 62(4):1017-36. PubMed ID: 26210630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma.
    Roldan-Romero JM; Beuselinck B; Santos M; Rodriguez-Moreno JF; Lanillos J; Calsina B; Gutierrez A; Tang K; Lainez N; Puente J; Castellano D; Esteban E; Climent MA; Arranz JA; Albersen M; Oudard S; Couchy G; Caleiras E; Montero-Conde C; Cascón A; Robledo M; Rodríguez-Antona C; García-Donas J;
    Int J Cancer; 2020 Mar; 146(5):1435-1444. PubMed ID: 31335987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus-Induced Hepatitis in Two Patients with Hyperinsulinemic Hypoglycemia.
    Haliloğlu B; Tüzün H; Flanagan SE; Çelik M; Kaya A; Ellard S; Özbek MN
    J Clin Res Pediatr Endocrinol; 2018 Jul; 10(3):279-283. PubMed ID: 29217498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective and safe use of sirolimus in hyperinsulinemic hypoglycaemia refractory to medical and surgical therapy: a case series and review of literature.
    Burnside MJ; Benitez-Aguirre P; Romans R; Gehrmann F; Velayutham V; Alexander A; Choong CS; Abraham MB
    J Pediatr Endocrinol Metab; 2024 Oct; 37(10):900-911. PubMed ID: 39190903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.